| University of Virginia School of Medicine | |
|---|---|
| Logo placeholder | |
| Location | Charlottesville, Virginia, USA |
| Type | Public Medical School |
| Website | https://med.virginia.edu/ |
| Focus Areas | Alzheimer's Disease, Parkinson's Disease, Neuroinflammation, Aging |
| Founded | 1819 |
University Of Virginia School Of Medicine is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
The University of Virginia School of Medicine is a public medical school located in Charlottesville, Virginia. Founded in 1819 by Thomas Jefferson, UVA School of Medicine is one of the oldest public medical schools in the United States. The school is part of the University of Virginia, a world-renowned research university founded by Thomas Jefferson in 1819.[1]
UVA has a distinguished history in neuroscience research, with major contributions to understanding neurodegenerative diseases, neural development, and neural circuitry.
The Center for Brain Immunology and Glia (BIG) at UVA is a premier research center focusing on the role of immune cells and glia in neurological diseases. Key research areas include:[2]
The Department of Neuroscience conducts research across the spectrum of nervous system function:
Key research programs include:
UVA Clinical Research:
| Disease | Research Focus |
|---|---|
| Alzheimer's Disease | Microglia, neuroinflammation, biomarkers |
| Parkinson's Disease | Alpha-synuclein, dopamine metabolism |
| Multiple Sclerosis | Demyelination, immune therapy |
| ALS | Motor neuron survival, biomarkers |
UVA researchers have made landmark discoveries in understanding how microglia contribute to neurodegenerative diseases. The identification of disease-associated microglia (DAM) and their role in Alzheimer's disease has opened new therapeutic avenues.[3]
The discovery of the brain's lymphatic system and glymphatic clearance pathway, led by Dr. Jonathan Kipnis, has revolutionized understanding of how the brain clears waste, with major implications for neurodegenerative diseases.[4]
Research on how chronic neuroinflammation contributes to neurodegeneration has identified new therapeutic targets for Alzheimer's and Parkinson's diseases.
UVA offers comprehensive training in neuroscience:
UVA maintains global research partnerships:
The study of University Of Virginia School Of Medicine has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
[1] "History of UVA School of Medicine." University of Virginia. https://med.virginia.edu/
[2] "Center for Brain Immunology and Glia." UVA. https://med.virginia.edu/big/
[3] Keren-Shaul H, et al. "A Unique Microglia Type Associated with Alzheimer's Disease." Cell. 2017.
[4] Iliff JJ, et al. "Brain-wide glymphatic pathway for CSF." J Clin Invest. 2013.
[5] "UVA Neuroscience Research." Department of Neuroscience. 2023.